Date Title Statement Presentation Report Webcast
7 September 2017

Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

  Presentation    
14 August 2017

Investor presentation, August 2017

  Presentation    
27 June 2016

AGM presentation 2016

  Presentation    
8 September 2015

Interim results presentation 2015

  Presentation    
28 April 2014

Results presentation to analysts 2014

  Presentation    
10 May 2013

Preliminary results presentation to analysts 2013

  Presentation    
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us